Cashu FinanceCashu Finance
  • Terminal
  • Spotlight
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. GRAL

Market Cap: $6.25B

GI

GRAIL Inc.

GRAL
NASDAQUSD
Purchase GRAL
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

–
–(–)

Open

$68.71

Prev. Close

$132.55

High

$70.36

Low

$68.43

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

CEOJoshua J. Ofman
SectorHealthcare

Recently from Cashu

GRAIL Inc. Faces New Challenges and Opportunities

GRAIL Inc. Faces New Challenges and Opportunities

GRAIL Inc. ( GRAL ) is currently at a critical juncture as it navigates the aftermath of its recent trial setback. After the public announcement of the disappointing results from its NHS-Galleri trial…

Cashu Finance·22 days ago
GRAIL Inc.: The Road Ahead After Setbacks

GRAIL Inc.: The Road Ahead After Setbacks

GRAIL Inc. ( GRAL ) is drawing attention as the latest developments come into focus. GRAIL Inc. (GRAL) is currently navigating a challenging landscape following the failure of its NHS-Galleri trial, w…

Cashu Finance·3 months ago
GRAIL Inc. Faces Trials and Tribulations

GRAIL Inc. Faces Trials and Tribulations

GRAIL Inc. (GRAL) is currently navigating a tumultuous landscape following major setbacks in its developmental pipeline and ensuing legal challenges. The company, once seen as a frontrunner in the bio…

Cashu Finance·3 months ago
GRAIL Inc.'s Road to Recovery

GRAIL Inc.'s Road to Recovery

GRAIL Inc. GRAL is currently navigating a complex and challenging landscape following the sobering results of its NHS-Galleri trial. The primary aim of this trial was to validate the efficacy of the G…

Cashu Finance·3 months ago
Industry
Medical - Diagnostics & Research
Employees910
IPO DateJun 12, 2024
ExchangeNASDAQ
Exchange NameNASDAQ
CurrencyUSD
Headquarters & Contact
Address1525 O’Brien Drive
City / State / ZIPMenlo Park, CA, 94025
CountryUnited States
Phone833-694-2553
Websitehttp://www.grail.com